NEFL and frontotemporal dementia: In this study, pNfH levels in all biofluids positively correlated with increases in disease progression.86 Both NfL and pNfH are also elevated in amyotrophic lateral sclerosis CSF and serum before symptom onset from nine months to 3.5 years.87 Receiver operating characteristics showed that CSF pNfH could differentiate amyotrophic lateral from amyotrophic lateral mimics.80 While further research is required, pNfH exhibits promise as a biomarker for both frontotemporal dementia and amyotrophic lateral sclerosis.